These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10431162)

  • 1. Fingerprinting disease with protein chip arrays.
    Senior K
    Mol Med Today; 1999 Aug; 5(8):326-7. PubMed ID: 10431162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular pathology and therapeutic perspectives of Alzheimer's disease].
    Iwatsubo T
    Nihon Ronen Igakkai Zasshi; 2005 Nov; 42(6):651-4. PubMed ID: 16408507
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular markers of Alzheimer disease early diagnostic: investigation perspectives of peripheral tissues.].
    Paltsev MA; Zuev VA; Kozhevnikova EO; Linkova NS; Kvetnaia TV; Polyakova VO; Kvetnoy IM
    Adv Gerontol; 2017; 30(6):809-817. PubMed ID: 29608821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new BACE is for therapy of Alzheimer's disease.
    Kahana J
    Trends Cell Biol; 2001 May; 11(5):192. PubMed ID: 11316595
    [No Abstract]   [Full Text] [Related]  

  • 5. Simple Colorimetric Detection of Amyloid β-peptide (1-40) based on Aggregation of Gold Nanoparticles in the Presence of Copper Ions.
    Zhou Y; Dong H; Liu L; Xu M
    Small; 2015 May; 11(18):2144-9. PubMed ID: 25641831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanism of deposition of amyloid beta-protein].
    Yanagisawa K
    No To Shinkei; 2001 Mar; 53(3):227-33. PubMed ID: 11296395
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein twists and turns in Alzheimer disease.
    Maudsley S; Mattson MP
    Nat Med; 2006 Apr; 12(4):392-3. PubMed ID: 16598285
    [No Abstract]   [Full Text] [Related]  

  • 8. Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
    Savage MJ; Holder DJ; Wu G; Kaplow J; Siuciak JA; Potter WZ;
    J Alzheimers Dis; 2015; 46(2):431-40. PubMed ID: 25790831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing and secretion of Alzheimer's disease amyloid precursor protein.
    Kinbara K; Kitagaki H; Kinouchi T; Okano M; Sorimachi H; Ishiura S; Suzuki K
    Tohoku J Exp Med; 1994 Nov; 174(3):209-16. PubMed ID: 7761986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the understanding of the processing of APP to beta amyloid peptide.
    Sinha S; Anderson J; John V; McConlogue L; Basi G; Thorsett E; Schenk D
    Ann N Y Acad Sci; 2000; 920():206-8. PubMed ID: 11193151
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity.
    Beher D; Wrigley JD; Owens AP; Shearman MS
    J Neurochem; 2002 Aug; 82(3):563-75. PubMed ID: 12153480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a sensitive mouse Aβ40 PD biomarker assay for Alzheimer's disease drug development in wild-type mice.
    Lu Y; Hoyte K; Montgomery WH; Luk W; He D; Meilandt WJ; Zuchero YJ; Atwal JK; Scearce-Levie K; Watts RJ; DeForge LE
    Bioanalysis; 2016 May; 8(10):1067-75. PubMed ID: 27094761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets.
    Olsson A; Vanmechelen E; Vanderstichele H; Davidsson P; Blennow K
    Dement Geriatr Cogn Disord; 2003; 16(2):93-7. PubMed ID: 12784033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression.
    Liu K; Doms RW; Lee VM
    Biochemistry; 2002 Mar; 41(9):3128-36. PubMed ID: 11863452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on BACE: the secretases as targets for treatment in Alzheimer disease.
    Dingwall C
    J Clin Invest; 2001 Nov; 108(9):1243-6. PubMed ID: 11696563
    [No Abstract]   [Full Text] [Related]  

  • 16. The brain's susceptibility to amyloid plaques.
    Wong PC; Price DL; Cai H
    Science; 2001 Aug; 293(5534):1434. PubMed ID: 11526940
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer disease: BACE1 inhibitor reduces β-amyloid production in humans.
    Crunkhorn S
    Nat Rev Drug Discov; 2016 Dec; 16(1):18. PubMed ID: 28031572
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer's disease: Mental plaque removal.
    De Strooper B; Woodgett J
    Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
    [No Abstract]   [Full Text] [Related]  

  • 19. A synthetic substrate assay for the gamma-secretase of the beta-A4 amyloid of Alzheimer's disease.
    Evin G; Beyreuther K; Masters CL
    J Pept Sci; 1995; 1(2):132-9. PubMed ID: 9222990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mouse models of Alzheimer's disease.
    Janus C; Chishti MA; Westaway D
    Biochim Biophys Acta; 2000 Jul; 1502(1):63-75. PubMed ID: 10899432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.